nodes	percent_of_prediction	percent_of_DWPC	metapath
Mianserin—HTR7—Parkinson's disease	0.143	0.192	CbGaD
Mianserin—DRD3—Parkinson's disease	0.134	0.181	CbGaD
Mianserin—SLC6A3—Parkinson's disease	0.125	0.168	CbGaD
Mianserin—HTR1A—Parkinson's disease	0.11	0.148	CbGaD
Mianserin—DRD2—Parkinson's disease	0.0931	0.125	CbGaD
Mianserin—HTR2A—Parkinson's disease	0.0719	0.0968	CbGaD
Mianserin—CYP2D6—Parkinson's disease	0.0658	0.0885	CbGaD
Mianserin—HTR7—enteric nervous system—Parkinson's disease	0.00422	0.0423	CbGeAlD
Mianserin—HTR7—superior cervical ganglion—Parkinson's disease	0.00404	0.0405	CbGeAlD
Mianserin—HTR7—myenteric nerve plexus—Parkinson's disease	0.0032	0.0321	CbGeAlD
Mianserin—DRD3—telencephalic ventricle—Parkinson's disease	0.00295	0.0296	CbGeAlD
Mianserin—SLC6A2—locus ceruleus—Parkinson's disease	0.00289	0.029	CbGeAlD
Mianserin—HTR7—locus ceruleus—Parkinson's disease	0.00279	0.0279	CbGeAlD
Mianserin—HTR2A—enteric nervous system—Parkinson's disease	0.00263	0.0264	CbGeAlD
Mianserin—SLC6A2—sympathetic nervous system—Parkinson's disease	0.00229	0.0229	CbGeAlD
Mianserin—HTR7—sympathetic nervous system—Parkinson's disease	0.0022	0.0221	CbGeAlD
Mianserin—HTR2A—myenteric nerve plexus—Parkinson's disease	0.00199	0.02	CbGeAlD
Mianserin—HTR2A—locus ceruleus—Parkinson's disease	0.00174	0.0174	CbGeAlD
Mianserin—SLC6A3—telencephalic ventricle—Parkinson's disease	0.0017	0.017	CbGeAlD
Mianserin—HTR1D—telencephalic ventricle—Parkinson's disease	0.00166	0.0166	CbGeAlD
Mianserin—HTR2C—telencephalic ventricle—Parkinson's disease	0.00164	0.0165	CbGeAlD
Mianserin—HTR7—pons—Parkinson's disease	0.00161	0.0161	CbGeAlD
Mianserin—SLC6A2—autonomic nervous system—Parkinson's disease	0.00154	0.0154	CbGeAlD
Mianserin—HTR7—autonomic nervous system—Parkinson's disease	0.00148	0.0149	CbGeAlD
Mianserin—HTR2A—cerebellar cortex—Parkinson's disease	0.00142	0.0142	CbGeAlD
Mianserin—HTR1A—telencephalic ventricle—Parkinson's disease	0.00138	0.0139	CbGeAlD
Mianserin—HTR2A—sympathetic nervous system—Parkinson's disease	0.00137	0.0138	CbGeAlD
Mianserin—HTR7—telencephalic ventricle—Parkinson's disease	0.00132	0.0133	CbGeAlD
Mianserin—DRD2—telencephalic ventricle—Parkinson's disease	0.00125	0.0125	CbGeAlD
Mianserin—HTR1F—forebrain—Parkinson's disease	0.00109	0.011	CbGeAlD
Mianserin—SLC6A3—nerve—Parkinson's disease	0.00107	0.0107	CbGeAlD
Mianserin—HTR7—peripheral nervous system—Parkinson's disease	0.00107	0.0107	CbGeAlD
Mianserin—HTR2A—pons—Parkinson's disease	0.001	0.01	CbGeAlD
Mianserin—HTR2A—autonomic nervous system—Parkinson's disease	0.000923	0.00926	CbGeAlD
Mianserin—SLC6A2—nerve—Parkinson's disease	0.000864	0.00867	CbGeAlD
Mianserin—HTR7—nerve—Parkinson's disease	0.000833	0.00835	CbGeAlD
Mianserin—HTR2A—telencephalic ventricle—Parkinson's disease	0.000824	0.00826	CbGeAlD
Mianserin—SLC6A3—hindbrain—Parkinson's disease	0.000802	0.00805	CbGeAlD
Mianserin—DRD2—nerve—Parkinson's disease	0.000787	0.0079	CbGeAlD
Mianserin—ADRA2A—peripheral nervous system—Parkinson's disease	0.000783	0.00786	CbGeAlD
Mianserin—HTR6—forebrain—Parkinson's disease	0.000742	0.00745	CbGeAlD
Mianserin—SLC6A4—hindbrain—Parkinson's disease	0.000735	0.00737	CbGeAlD
Mianserin—OPRK1—forebrain—Parkinson's disease	0.000687	0.00689	CbGeAlD
Mianserin—HTR2A—peripheral nervous system—Parkinson's disease	0.000666	0.00668	CbGeAlD
Mianserin—HTR1A—hindbrain—Parkinson's disease	0.000653	0.00655	CbGeAlD
Mianserin—HTR1F—head—Parkinson's disease	0.000625	0.00627	CbGeAlD
Mianserin—HTR7—hindbrain—Parkinson's disease	0.000624	0.00626	CbGeAlD
Mianserin—HTR1F—nervous system—Parkinson's disease	0.000593	0.00595	CbGeAlD
Mianserin—DRD2—hindbrain—Parkinson's disease	0.00059	0.00592	CbGeAlD
Mianserin—HRH2—cardiovascular system—Parkinson's disease	0.000574	0.00576	CbGeAlD
Mianserin—HTR1F—central nervous system—Parkinson's disease	0.000571	0.00572	CbGeAlD
Mianserin—HTR2A—nerve—Parkinson's disease	0.000519	0.00521	CbGeAlD
Mianserin—SLC6A3—brainstem—Parkinson's disease	0.00046	0.00461	CbGeAlD
Mianserin—HTR1F—brain—Parkinson's disease	0.000453	0.00454	CbGeAlD
Mianserin—HTR1D—brainstem—Parkinson's disease	0.000449	0.0045	CbGeAlD
Mianserin—HTR2C—brainstem—Parkinson's disease	0.000444	0.00446	CbGeAlD
Mianserin—SLC6A3—forebrain—Parkinson's disease	0.000444	0.00445	CbGeAlD
Mianserin—DRD3—head—Parkinson's disease	0.000442	0.00443	CbGeAlD
Mianserin—HTR1D—forebrain—Parkinson's disease	0.000433	0.00434	CbGeAlD
Mianserin—HTR2C—forebrain—Parkinson's disease	0.000429	0.0043	CbGeAlD
Mianserin—HTR6—head—Parkinson's disease	0.000425	0.00426	CbGeAlD
Mianserin—SLC6A4—brainstem—Parkinson's disease	0.000421	0.00423	CbGeAlD
Mianserin—DRD3—nervous system—Parkinson's disease	0.000419	0.0042	CbGeAlD
Mianserin—SLC6A4—forebrain—Parkinson's disease	0.000407	0.00408	CbGeAlD
Mianserin—DRD3—central nervous system—Parkinson's disease	0.000403	0.00404	CbGeAlD
Mianserin—HTR6—nervous system—Parkinson's disease	0.000403	0.00404	CbGeAlD
Mianserin—HTR2B—forebrain—Parkinson's disease	0.000403	0.00404	CbGeAlD
Mianserin—OPRK1—head—Parkinson's disease	0.000394	0.00395	CbGeAlD
Mianserin—HTR2A—hindbrain—Parkinson's disease	0.000389	0.0039	CbGeAlD
Mianserin—HRH2—head—Parkinson's disease	0.000389	0.0039	CbGeAlD
Mianserin—HTR6—central nervous system—Parkinson's disease	0.000388	0.00389	CbGeAlD
Mianserin—HTR1A—brainstem—Parkinson's disease	0.000374	0.00375	CbGeAlD
Mianserin—OPRK1—nervous system—Parkinson's disease	0.000373	0.00374	CbGeAlD
Mianserin—SLC6A2—brainstem—Parkinson's disease	0.000371	0.00372	CbGeAlD
Mianserin—HRH2—nervous system—Parkinson's disease	0.000368	0.0037	CbGeAlD
Mianserin—HTR1D—cardiovascular system—Parkinson's disease	0.000366	0.00367	CbGeAlD
Mianserin—HTR1A—forebrain—Parkinson's disease	0.000361	0.00362	CbGeAlD
Mianserin—OPRK1—central nervous system—Parkinson's disease	0.000359	0.0036	CbGeAlD
Mianserin—SLC6A2—forebrain—Parkinson's disease	0.000358	0.00359	CbGeAlD
Mianserin—HTR7—brainstem—Parkinson's disease	0.000358	0.00359	CbGeAlD
Mianserin—HRH2—central nervous system—Parkinson's disease	0.000355	0.00356	CbGeAlD
Mianserin—CYP2D6—hindbrain—Parkinson's disease	0.000354	0.00355	CbGeAlD
Mianserin—OPRK1—cerebellum—Parkinson's disease	0.000351	0.00352	CbGeAlD
Mianserin—HTR7—forebrain—Parkinson's disease	0.000345	0.00346	CbGeAlD
Mianserin—HTR2B—cardiovascular system—Parkinson's disease	0.000341	0.00342	CbGeAlD
Mianserin—DRD2—brainstem—Parkinson's disease	0.000338	0.00339	CbGeAlD
Mianserin—DRD2—forebrain—Parkinson's disease	0.000326	0.00327	CbGeAlD
Mianserin—DRD3—brain—Parkinson's disease	0.00032	0.00321	CbGeAlD
Mianserin—Diphenylpyraline—SLC6A3—Parkinson's disease	0.000315	0.0544	CrCbGaD
Mianserin—HTR2C—medulla oblongata—Parkinson's disease	0.00031	0.00311	CbGeAlD
Mianserin—HTR6—brain—Parkinson's disease	0.000308	0.00309	CbGeAlD
Mianserin—HTR1A—cardiovascular system—Parkinson's disease	0.000305	0.00306	CbGeAlD
Mianserin—Epinastine—HTR7—Parkinson's disease	0.000297	0.0513	CrCbGaD
Mianserin—SLC6A3—midbrain—Parkinson's disease	0.000293	0.00294	CbGeAlD
Mianserin—HTR7—cardiovascular system—Parkinson's disease	0.000292	0.00293	CbGeAlD
Mianserin—HTR1D—midbrain—Parkinson's disease	0.000286	0.00287	CbGeAlD
Mianserin—SLC6A3—spinal cord—Parkinson's disease	0.000286	0.00287	CbGeAlD
Mianserin—OPRK1—brain—Parkinson's disease	0.000285	0.00286	CbGeAlD
Mianserin—HTR2C—midbrain—Parkinson's disease	0.000283	0.00284	CbGeAlD
Mianserin—HRH2—brain—Parkinson's disease	0.000282	0.00282	CbGeAlD
Mianserin—HTR2C—spinal cord—Parkinson's disease	0.000276	0.00277	CbGeAlD
Mianserin—SLC6A4—midbrain—Parkinson's disease	0.000269	0.00269	CbGeAlD
Mianserin—SLC6A4—spinal cord—Parkinson's disease	0.000262	0.00263	CbGeAlD
Mianserin—SLC6A2—medulla oblongata—Parkinson's disease	0.000259	0.00259	CbGeAlD
Mianserin—HRH1—forebrain—Parkinson's disease	0.000258	0.00258	CbGeAlD
Mianserin—SLC6A3—head—Parkinson's disease	0.000254	0.00255	CbGeAlD
Mianserin—ADRA2A—forebrain—Parkinson's disease	0.000253	0.00254	CbGeAlD
Mianserin—HTR7—medulla oblongata—Parkinson's disease	0.000249	0.0025	CbGeAlD
Mianserin—HTR1D—head—Parkinson's disease	0.000248	0.00249	CbGeAlD
Mianserin—HTR2C—head—Parkinson's disease	0.000246	0.00246	CbGeAlD
Mianserin—HTR2A—embryo—Parkinson's disease	0.000243	0.00244	CbGeAlD
Mianserin—SLC6A3—nervous system—Parkinson's disease	0.000241	0.00242	CbGeAlD
Mianserin—HTR1A—midbrain—Parkinson's disease	0.000238	0.00239	CbGeAlD
Mianserin—HTR1D—nervous system—Parkinson's disease	0.000235	0.00236	CbGeAlD
Mianserin—Mirtazapine—HTR7—Parkinson's disease	0.000234	0.0404	CrCbGaD
Mianserin—HTR2C—nervous system—Parkinson's disease	0.000233	0.00234	CbGeAlD
Mianserin—SLC6A4—head—Parkinson's disease	0.000233	0.00234	CbGeAlD
Mianserin—HTR1A—spinal cord—Parkinson's disease	0.000233	0.00233	CbGeAlD
Mianserin—SLC6A3—central nervous system—Parkinson's disease	0.000232	0.00233	CbGeAlD
Mianserin—HTR2B—head—Parkinson's disease	0.000231	0.00231	CbGeAlD
Mianserin—ADRA2C—medulla oblongata—Parkinson's disease	0.000229	0.0023	CbGeAlD
Mianserin—HTR7—midbrain—Parkinson's disease	0.000228	0.00229	CbGeAlD
Mianserin—SLC6A3—cerebellum—Parkinson's disease	0.000227	0.00227	CbGeAlD
Mianserin—HTR1D—central nervous system—Parkinson's disease	0.000226	0.00227	CbGeAlD
Mianserin—HTR2C—central nervous system—Parkinson's disease	0.000224	0.00225	CbGeAlD
Mianserin—CYP2B6—cardiovascular system—Parkinson's disease	0.000223	0.00224	CbGeAlD
Mianserin—HTR2A—brainstem—Parkinson's disease	0.000223	0.00224	CbGeAlD
Mianserin—HTR7—spinal cord—Parkinson's disease	0.000222	0.00223	CbGeAlD
Mianserin—SLC6A4—nervous system—Parkinson's disease	0.000221	0.00221	CbGeAlD
Mianserin—Mirtazapine—DRD3—Parkinson's disease	0.00022	0.0379	CrCbGaD
Mianserin—HTR2B—nervous system—Parkinson's disease	0.000219	0.00219	CbGeAlD
Mianserin—DRD2—midbrain—Parkinson's disease	0.000215	0.00216	CbGeAlD
Mianserin—HTR2A—forebrain—Parkinson's disease	0.000215	0.00216	CbGeAlD
Mianserin—SLC6A4—central nervous system—Parkinson's disease	0.000213	0.00213	CbGeAlD
Mianserin—HTR2B—central nervous system—Parkinson's disease	0.000211	0.00211	CbGeAlD
Mianserin—ADRA2C—midbrain—Parkinson's disease	0.000209	0.0021	CbGeAlD
Mianserin—HTR1A—head—Parkinson's disease	0.000207	0.00207	CbGeAlD
Mianserin—SLC6A2—head—Parkinson's disease	0.000205	0.00206	CbGeAlD
Mianserin—ADRA2C—spinal cord—Parkinson's disease	0.000204	0.00205	CbGeAlD
Mianserin—Mirtazapine—SLC6A3—Parkinson's disease	0.000204	0.0353	CrCbGaD
Mianserin—CYP2D6—brainstem—Parkinson's disease	0.000203	0.00204	CbGeAlD
Mianserin—HTR7—head—Parkinson's disease	0.000198	0.00198	CbGeAlD
Mianserin—CYP2D6—forebrain—Parkinson's disease	0.000196	0.00197	CbGeAlD
Mianserin—HTR1A—nervous system—Parkinson's disease	0.000196	0.00197	CbGeAlD
Mianserin—SLC6A2—nervous system—Parkinson's disease	0.000194	0.00195	CbGeAlD
Mianserin—HTR1A—central nervous system—Parkinson's disease	0.000189	0.00189	CbGeAlD
Mianserin—HTR7—nervous system—Parkinson's disease	0.000187	0.00188	CbGeAlD
Mianserin—SLC6A2—central nervous system—Parkinson's disease	0.000187	0.00188	CbGeAlD
Mianserin—DRD2—head—Parkinson's disease	0.000187	0.00187	CbGeAlD
Mianserin—HTR1A—cerebellum—Parkinson's disease	0.000184	0.00185	CbGeAlD
Mianserin—SLC6A3—brain—Parkinson's disease	0.000184	0.00185	CbGeAlD
Mianserin—ADRA2A—medulla oblongata—Parkinson's disease	0.000183	0.00183	CbGeAlD
Mianserin—HTR2A—cardiovascular system—Parkinson's disease	0.000182	0.00182	CbGeAlD
Mianserin—ADRA2C—head—Parkinson's disease	0.000182	0.00182	CbGeAlD
Mianserin—HTR7—central nervous system—Parkinson's disease	0.00018	0.00181	CbGeAlD
Mianserin—HTR1D—brain—Parkinson's disease	0.00018	0.0018	CbGeAlD
Mianserin—Mirtazapine—HTR1A—Parkinson's disease	0.000179	0.0309	CrCbGaD
Mianserin—Prochlorperazine—DRD3—Parkinson's disease	0.000178	0.0308	CrCbGaD
Mianserin—HTR2C—brain—Parkinson's disease	0.000178	0.00179	CbGeAlD
Mianserin—DRD2—nervous system—Parkinson's disease	0.000177	0.00178	CbGeAlD
Mianserin—HTR7—cerebellum—Parkinson's disease	0.000176	0.00177	CbGeAlD
Mianserin—Cyproheptadine—HTR1A—Parkinson's disease	0.000174	0.03	CrCbGaD
Mianserin—ADRA2C—nervous system—Parkinson's disease	0.000172	0.00173	CbGeAlD
Mianserin—DRD2—central nervous system—Parkinson's disease	0.00017	0.00171	CbGeAlD
Mianserin—SLC6A4—brain—Parkinson's disease	0.000169	0.00169	CbGeAlD
Mianserin—HTR2B—brain—Parkinson's disease	0.000167	0.00168	CbGeAlD
Mianserin—ADRA2A—midbrain—Parkinson's disease	0.000167	0.00168	CbGeAlD
Mianserin—DRD2—cerebellum—Parkinson's disease	0.000167	0.00167	CbGeAlD
Mianserin—ADRA2C—central nervous system—Parkinson's disease	0.000166	0.00166	CbGeAlD
Mianserin—ADRA2A—spinal cord—Parkinson's disease	0.000163	0.00164	CbGeAlD
Mianserin—ADRA2C—cerebellum—Parkinson's disease	0.000162	0.00163	CbGeAlD
Mianserin—HTR2A—medulla oblongata—Parkinson's disease	0.000155	0.00156	CbGeAlD
Mianserin—Mirtazapine—DRD2—Parkinson's disease	0.000152	0.0263	CrCbGaD
Mianserin—CYP2B6—head—Parkinson's disease	0.000151	0.00152	CbGeAlD
Mianserin—HTR1A—brain—Parkinson's disease	0.00015	0.0015	CbGeAlD
Mianserin—Epinastine—HTR2A—Parkinson's disease	0.000149	0.0258	CrCbGaD
Mianserin—SLC6A2—brain—Parkinson's disease	0.000149	0.00149	CbGeAlD
Mianserin—HRH1—head—Parkinson's disease	0.000148	0.00148	CbGeAlD
Mianserin—Cyproheptadine—DRD2—Parkinson's disease	0.000147	0.0255	CrCbGaD
Mianserin—ADRA2A—head—Parkinson's disease	0.000145	0.00145	CbGeAlD
Mianserin—CYP2B6—nervous system—Parkinson's disease	0.000143	0.00144	CbGeAlD
Mianserin—HTR7—brain—Parkinson's disease	0.000143	0.00144	CbGeAlD
Mianserin—HTR2A—midbrain—Parkinson's disease	0.000142	0.00143	CbGeAlD
Mianserin—HRH1—nervous system—Parkinson's disease	0.00014	0.0014	CbGeAlD
Mianserin—HTR2A—spinal cord—Parkinson's disease	0.000139	0.00139	CbGeAlD
Mianserin—CYP2B6—central nervous system—Parkinson's disease	0.000138	0.00138	CbGeAlD
Mianserin—ADRA2A—nervous system—Parkinson's disease	0.000137	0.00138	CbGeAlD
Mianserin—Epinastine—CYP2D6—Parkinson's disease	0.000136	0.0236	CrCbGaD
Mianserin—DRD2—brain—Parkinson's disease	0.000135	0.00136	CbGeAlD
Mianserin—HRH1—central nervous system—Parkinson's disease	0.000135	0.00135	CbGeAlD
Mianserin—ADRA2A—central nervous system—Parkinson's disease	0.000132	0.00133	CbGeAlD
Mianserin—ADRA2C—brain—Parkinson's disease	0.000132	0.00132	CbGeAlD
Mianserin—ADRA2A—cerebellum—Parkinson's disease	0.000129	0.0013	CbGeAlD
Mianserin—Mequitazine—CYP2D6—Parkinson's disease	0.000128	0.0222	CrCbGaD
Mianserin—Trimipramine—SLC6A3—Parkinson's disease	0.000126	0.0218	CrCbGaD
Mianserin—Prochlorperazine—DRD2—Parkinson's disease	0.000123	0.0213	CrCbGaD
Mianserin—HTR2A—head—Parkinson's disease	0.000123	0.00124	CbGeAlD
Mianserin—Nortriptyline—HTR1A—Parkinson's disease	0.000118	0.0203	CrCbGaD
Mianserin—Mirtazapine—HTR2A—Parkinson's disease	0.000117	0.0203	CrCbGaD
Mianserin—HTR2A—nervous system—Parkinson's disease	0.000117	0.00117	CbGeAlD
Mianserin—Cyproheptadine—HTR2A—Parkinson's disease	0.000114	0.0197	CrCbGaD
Mianserin—HTR2A—central nervous system—Parkinson's disease	0.000112	0.00113	CbGeAlD
Mianserin—CYP2D6—head—Parkinson's disease	0.000112	0.00113	CbGeAlD
Mianserin—Trimipramine—HTR1A—Parkinson's disease	0.000111	0.0191	CrCbGaD
Mianserin—Desipramine—SLC6A3—Parkinson's disease	0.00011	0.0191	CrCbGaD
Mianserin—HTR2A—cerebellum—Parkinson's disease	0.00011	0.0011	CbGeAlD
Mianserin—CYP2B6—brain—Parkinson's disease	0.000109	0.0011	CbGeAlD
Mianserin—CYP3A4—nervous system—Parkinson's disease	0.000108	0.00108	CbGeAlD
Mianserin—Mirtazapine—CYP2D6—Parkinson's disease	0.000107	0.0186	CrCbGaD
Mianserin—Imipramine—HTR7—Parkinson's disease	0.000107	0.0185	CrCbGaD
Mianserin—HRH1—brain—Parkinson's disease	0.000107	0.00107	CbGeAlD
Mianserin—Amitriptyline—HTR7—Parkinson's disease	0.000106	0.0184	CrCbGaD
Mianserin—CYP2D6—nervous system—Parkinson's disease	0.000106	0.00107	CbGeAlD
Mianserin—ADRA2A—brain—Parkinson's disease	0.000105	0.00105	CbGeAlD
Mianserin—CYP3A4—central nervous system—Parkinson's disease	0.000104	0.00104	CbGeAlD
Mianserin—CYP2D6—central nervous system—Parkinson's disease	0.000102	0.00103	CbGeAlD
Mianserin—CYP2D6—cerebellum—Parkinson's disease	0.0001	0.001	CbGeAlD
Mianserin—Amitriptyline—DRD3—Parkinson's disease	0.0001	0.0173	CrCbGaD
Mianserin—Nortriptyline—DRD2—Parkinson's disease	9.98e-05	0.0172	CrCbGaD
Mianserin—Epinastine—ABCB1—Parkinson's disease	9.74e-05	0.0168	CrCbGaD
Mianserin—Desipramine—HTR1A—Parkinson's disease	9.68e-05	0.0167	CrCbGaD
Mianserin—Nortriptyline—CYP2E1—Parkinson's disease	9.61e-05	0.0166	CrCbGaD
Mianserin—Trimipramine—DRD2—Parkinson's disease	9.4e-05	0.0162	CrCbGaD
Mianserin—Imipramine—SLC6A3—Parkinson's disease	9.37e-05	0.0162	CrCbGaD
Mianserin—HTR2A—brain—Parkinson's disease	8.93e-05	0.000896	CbGeAlD
Mianserin—Prochlorperazine—CYP2D6—Parkinson's disease	8.73e-05	0.0151	CrCbGaD
Mianserin—Desipramine—DRD2—Parkinson's disease	8.22e-05	0.0142	CrCbGaD
Mianserin—Imipramine—HTR1A—Parkinson's disease	8.21e-05	0.0142	CrCbGaD
Mianserin—Amitriptyline—HTR1A—Parkinson's disease	8.16e-05	0.0141	CrCbGaD
Mianserin—CYP2D6—brain—Parkinson's disease	8.13e-05	0.000816	CbGeAlD
Mianserin—Desipramine—CYP2E1—Parkinson's disease	7.91e-05	0.0137	CrCbGaD
Mianserin—Nortriptyline—HTR2A—Parkinson's disease	7.71e-05	0.0133	CrCbGaD
Mianserin—Trimipramine—HTR2A—Parkinson's disease	7.26e-05	0.0125	CrCbGaD
Mianserin—Nortriptyline—CYP2D6—Parkinson's disease	7.05e-05	0.0122	CrCbGaD
Mianserin—Imipramine—DRD2—Parkinson's disease	6.97e-05	0.012	CrCbGaD
Mianserin—Amitriptyline—DRD2—Parkinson's disease	6.93e-05	0.012	CrCbGaD
Mianserin—Imipramine—CYP2E1—Parkinson's disease	6.71e-05	0.0116	CrCbGaD
Mianserin—Amitriptyline—CYP2E1—Parkinson's disease	6.67e-05	0.0115	CrCbGaD
Mianserin—Trimipramine—CYP2D6—Parkinson's disease	6.64e-05	0.0115	CrCbGaD
Mianserin—Desipramine—HTR2A—Parkinson's disease	6.35e-05	0.011	CrCbGaD
Mianserin—Desipramine—CYP2D6—Parkinson's disease	5.81e-05	0.01	CrCbGaD
Mianserin—Imipramine—HTR2A—Parkinson's disease	5.38e-05	0.0093	CrCbGaD
Mianserin—Amitriptyline—HTR2A—Parkinson's disease	5.35e-05	0.00925	CrCbGaD
Mianserin—Imipramine—CYP2D6—Parkinson's disease	4.92e-05	0.00851	CrCbGaD
Mianserin—Amitriptyline—CYP2D6—Parkinson's disease	4.89e-05	0.00846	CrCbGaD
Mianserin—Trimipramine—ABCB1—Parkinson's disease	4.74e-05	0.00819	CrCbGaD
Mianserin—Desipramine—ABCB1—Parkinson's disease	4.15e-05	0.00716	CrCbGaD
Mianserin—Imipramine—ABCB1—Parkinson's disease	3.52e-05	0.00608	CrCbGaD
Mianserin—Amitriptyline—ABCB1—Parkinson's disease	3.49e-05	0.00604	CrCbGaD
Mianserin—CYP1A2—Metabolism—DDC—Parkinson's disease	5.92e-06	3.91e-05	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—HTR2A—Parkinson's disease	5.91e-06	3.91e-05	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—HTR2A—Parkinson's disease	5.91e-06	3.9e-05	CbGpPWpGaD
Mianserin—ADRA2C—Metabolism—ABCB1—Parkinson's disease	5.9e-06	3.9e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—MAOB—Parkinson's disease	5.88e-06	3.89e-05	CbGpPWpGaD
Mianserin—HRH4—Signaling Pathways—CASP3—Parkinson's disease	5.88e-06	3.89e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—HTR2A—Parkinson's disease	5.87e-06	3.88e-05	CbGpPWpGaD
Mianserin—HRH4—Signaling by GPCR—IL6—Parkinson's disease	5.84e-06	3.86e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—FGB—Parkinson's disease	5.84e-06	3.86e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling by GPCR—HTR2A—Parkinson's disease	5.82e-06	3.85e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—IGF1R—Parkinson's disease	5.81e-06	3.84e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—HTR1A—Parkinson's disease	5.81e-06	3.84e-05	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—CYP2E1—Parkinson's disease	5.75e-06	3.8e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—EDN1—Parkinson's disease	5.74e-06	3.79e-05	CbGpPWpGaD
Mianserin—ADRA2A—Metabolism—CYCS—Parkinson's disease	5.74e-06	3.79e-05	CbGpPWpGaD
Mianserin—ADRA2C—Metabolism—GSTM1—Parkinson's disease	5.72e-06	3.78e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—TAC1—Parkinson's disease	5.72e-06	3.78e-05	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—NQO1—Parkinson's disease	5.69e-06	3.76e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—NGF—Parkinson's disease	5.67e-06	3.75e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—ADRBK1—Parkinson's disease	5.67e-06	3.74e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—DRD1—Parkinson's disease	5.61e-06	3.71e-05	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—TH—Parkinson's disease	5.6e-06	3.7e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—GSTA4—Parkinson's disease	5.59e-06	3.69e-05	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—APOE—Parkinson's disease	5.58e-06	3.69e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—ADRBK1—Parkinson's disease	5.57e-06	3.68e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—ADRBK1—Parkinson's disease	5.56e-06	3.68e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	5.52e-06	3.65e-05	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—APOE—Parkinson's disease	5.5e-06	3.63e-05	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—APOE—Parkinson's disease	5.49e-06	3.63e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—HTR7—Parkinson's disease	5.49e-06	3.63e-05	CbGpPWpGaD
Mianserin—ADRA2C—Metabolism—GPX1—Parkinson's disease	5.48e-06	3.62e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—APOE—Parkinson's disease	5.45e-06	3.61e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—DRD3—Parkinson's disease	5.43e-06	3.59e-05	CbGpPWpGaD
Mianserin—HTR1F—Signaling Pathways—CASP3—Parkinson's disease	5.43e-06	3.59e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—IGF2—Parkinson's disease	5.42e-06	3.59e-05	CbGpPWpGaD
Mianserin—HRH4—Signaling Pathways—MAPK8—Parkinson's disease	5.4e-06	3.57e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—HTR7—Parkinson's disease	5.4e-06	3.57e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—DRD2—Parkinson's disease	5.4e-06	3.57e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—HTR2A—Parkinson's disease	5.4e-06	3.57e-05	CbGpPWpGaD
Mianserin—HTR1F—Signaling by GPCR—IL6—Parkinson's disease	5.39e-06	3.56e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—HTR7—Parkinson's disease	5.39e-06	3.56e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—DRD2—Parkinson's disease	5.39e-06	3.56e-05	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—CYCS—Parkinson's disease	5.38e-06	3.56e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—NGF—Parkinson's disease	5.28e-06	3.49e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—IGF1R—Parkinson's disease	5.24e-06	3.47e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—IGF2—Parkinson's disease	5.24e-06	3.46e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—IGF2—Parkinson's disease	5.21e-06	3.44e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—EDN1—Parkinson's disease	5.18e-06	3.43e-05	CbGpPWpGaD
Mianserin—ADRA2A—Metabolism—COMT—Parkinson's disease	5.08e-06	3.36e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—ADRBK1—Parkinson's disease	5.07e-06	3.35e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—IGF2—Parkinson's disease	5.07e-06	3.35e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—IGF1R—Parkinson's disease	5.06e-06	3.35e-05	CbGpPWpGaD
Mianserin—ADRA2A—Metabolism—GSTP1—Parkinson's disease	5.06e-06	3.34e-05	CbGpPWpGaD
Mianserin—ADRA2C—Metabolism—MTHFR—Parkinson's disease	5.06e-06	3.34e-05	CbGpPWpGaD
Mianserin—ADRA2A—Metabolism—MAOA—Parkinson's disease	5.05e-06	3.34e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—IGF1R—Parkinson's disease	5.04e-06	3.33e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—PLA2G6—Parkinson's disease	5.03e-06	3.33e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—HTR2A—Parkinson's disease	5.02e-06	3.32e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—APOE—Parkinson's disease	5.02e-06	3.32e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—EDN1—Parkinson's disease	5e-06	3.31e-05	CbGpPWpGaD
Mianserin—ADRA2A—Metabolism—HMOX1—Parkinson's disease	4.99e-06	3.3e-05	CbGpPWpGaD
Mianserin—HTR1F—Signaling Pathways—MAPK8—Parkinson's disease	4.99e-06	3.3e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—MAOB—Parkinson's disease	4.98e-06	3.29e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—EDN1—Parkinson's disease	4.98e-06	3.29e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—DRD2—Parkinson's disease	4.91e-06	3.25e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—HTR7—Parkinson's disease	4.91e-06	3.25e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—IGF1R—Parkinson's disease	4.9e-06	3.24e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—EDN1—Parkinson's disease	4.84e-06	3.2e-05	CbGpPWpGaD
Mianserin—ADRA2A—Metabolism—ABCB1—Parkinson's disease	4.79e-06	3.16e-05	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—COMT—Parkinson's disease	4.76e-06	3.15e-05	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—INS—Parkinson's disease	4.76e-06	3.15e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—NGF—Parkinson's disease	4.76e-06	3.15e-05	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—GSTP1—Parkinson's disease	4.74e-06	3.13e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	4.74e-06	3.13e-05	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—MAOA—Parkinson's disease	4.73e-06	3.13e-05	CbGpPWpGaD
Mianserin—ADRA2C—Metabolism—APOE—Parkinson's disease	4.71e-06	3.11e-05	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—INS—Parkinson's disease	4.7e-06	3.1e-05	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—INS—Parkinson's disease	4.69e-06	3.1e-05	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—HMOX1—Parkinson's disease	4.68e-06	3.09e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—APOE—Parkinson's disease	4.67e-06	3.09e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—INS—Parkinson's disease	4.66e-06	3.08e-05	CbGpPWpGaD
Mianserin—ADRA2A—Metabolism—GSTM1—Parkinson's disease	4.65e-06	3.07e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—IGF2—Parkinson's disease	4.6e-06	3.04e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—NGF—Parkinson's disease	4.6e-06	3.04e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—NGF—Parkinson's disease	4.57e-06	3.02e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—DDC—Parkinson's disease	4.57e-06	3.02e-05	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—CASP3—Parkinson's disease	4.56e-06	3.01e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—HTR2A—Parkinson's disease	4.53e-06	3e-05	CbGpPWpGaD
Mianserin—HRH2—Signaling by GPCR—IL6—Parkinson's disease	4.53e-06	2.99e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—IGF2—Parkinson's disease	4.52e-06	2.99e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—IGF2—Parkinson's disease	4.51e-06	2.98e-05	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—ABCB1—Parkinson's disease	4.49e-06	2.97e-05	CbGpPWpGaD
Mianserin—ADRA2A—Metabolism—GPX1—Parkinson's disease	4.45e-06	2.94e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—NGF—Parkinson's disease	4.45e-06	2.94e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—IGF1R—Parkinson's disease	4.45e-06	2.94e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—EDN1—Parkinson's disease	4.39e-06	2.9e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—HTR2A—Parkinson's disease	4.38e-06	2.89e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—IGF1R—Parkinson's disease	4.37e-06	2.89e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—IGF1R—Parkinson's disease	4.36e-06	2.88e-05	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—GSTM1—Parkinson's disease	4.36e-06	2.88e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—HTR2A—Parkinson's disease	4.35e-06	2.88e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—EDN1—Parkinson's disease	4.32e-06	2.86e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—GSTA4—Parkinson's disease	4.31e-06	2.85e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—EDN1—Parkinson's disease	4.31e-06	2.85e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—CTGF—Parkinson's disease	4.29e-06	2.83e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—INS—Parkinson's disease	4.29e-06	2.83e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—HTR2A—Parkinson's disease	4.24e-06	2.8e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—APOE—Parkinson's disease	4.22e-06	2.79e-05	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—MAPK8—Parkinson's disease	4.19e-06	2.77e-05	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—GPX1—Parkinson's disease	4.17e-06	2.76e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—IGF2—Parkinson's disease	4.12e-06	2.72e-05	CbGpPWpGaD
Mianserin—ADRA2A—Metabolism—MTHFR—Parkinson's disease	4.11e-06	2.72e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—APOE—Parkinson's disease	4.07e-06	2.69e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—APOE—Parkinson's disease	4.05e-06	2.68e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—NGF—Parkinson's disease	4.04e-06	2.67e-05	CbGpPWpGaD
Mianserin—ADRA2C—Metabolism—INS—Parkinson's disease	4.02e-06	2.66e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—CYP2E1—Parkinson's disease	4e-06	2.64e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—INS—Parkinson's disease	3.99e-06	2.64e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—IGF1R—Parkinson's disease	3.98e-06	2.63e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—NGF—Parkinson's disease	3.97e-06	2.62e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—NGF—Parkinson's disease	3.96e-06	2.62e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—NQO1—Parkinson's disease	3.95e-06	2.61e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—APOE—Parkinson's disease	3.94e-06	2.6e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—EDN1—Parkinson's disease	3.93e-06	2.6e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—TH—Parkinson's disease	3.89e-06	2.57e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	3.88e-06	2.57e-05	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—MTHFR—Parkinson's disease	3.85e-06	2.55e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—MAOB—Parkinson's disease	3.84e-06	2.54e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—HTR2A—Parkinson's disease	3.84e-06	2.54e-05	CbGpPWpGaD
Mianserin—ADRA2A—Metabolism—APOE—Parkinson's disease	3.82e-06	2.53e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—HTR2A—Parkinson's disease	3.77e-06	2.49e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—CYCS—Parkinson's disease	3.74e-06	2.47e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—CYP2D6—Parkinson's disease	3.7e-06	2.45e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—CTGF—Parkinson's disease	3.63e-06	2.4e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—NGF—Parkinson's disease	3.61e-06	2.39e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—INS—Parkinson's disease	3.6e-06	2.38e-05	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—APOE—Parkinson's disease	3.59e-06	2.37e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—APOE—Parkinson's disease	3.57e-06	2.36e-05	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—CASP3—Parkinson's disease	3.55e-06	2.34e-05	CbGpPWpGaD
Mianserin—OPRK1—Signaling by GPCR—IL6—Parkinson's disease	3.52e-06	2.33e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—APOE—Parkinson's disease	3.52e-06	2.32e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—APOE—Parkinson's disease	3.51e-06	2.32e-05	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—CASP3—Parkinson's disease	3.5e-06	2.31e-05	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—CASP3—Parkinson's disease	3.49e-06	2.31e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—INS—Parkinson's disease	3.48e-06	2.3e-05	CbGpPWpGaD
Mianserin—HTR6—Signaling by GPCR—IL6—Parkinson's disease	3.47e-06	2.3e-05	CbGpPWpGaD
Mianserin—HTR7—Signaling by GPCR—IL6—Parkinson's disease	3.47e-06	2.29e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—CASP3—Parkinson's disease	3.47e-06	2.29e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—INS—Parkinson's disease	3.46e-06	2.29e-05	CbGpPWpGaD
Mianserin—HRH4—Signaling Pathways—IL6—Parkinson's disease	3.45e-06	2.28e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling by GPCR—IL6—Parkinson's disease	3.45e-06	2.28e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—HTR2A—Parkinson's disease	3.44e-06	2.27e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—CYP2E1—Parkinson's disease	3.39e-06	2.24e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—INS—Parkinson's disease	3.36e-06	2.22e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—NQO1—Parkinson's disease	3.35e-06	2.21e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—COMT—Parkinson's disease	3.31e-06	2.19e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—TH—Parkinson's disease	3.3e-06	2.18e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—GSTP1—Parkinson's disease	3.3e-06	2.18e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—MAOA—Parkinson's disease	3.29e-06	2.17e-05	CbGpPWpGaD
Mianserin—ADRA2A—Metabolism—INS—Parkinson's disease	3.27e-06	2.16e-05	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—MAPK8—Parkinson's disease	3.26e-06	2.15e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—HMOX1—Parkinson's disease	3.25e-06	2.15e-05	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—MAPK8—Parkinson's disease	3.21e-06	2.12e-05	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—MAPK8—Parkinson's disease	3.21e-06	2.12e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—APOE—Parkinson's disease	3.2e-06	2.11e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—CASP3—Parkinson's disease	3.19e-06	2.11e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—MAPK8—Parkinson's disease	3.19e-06	2.11e-05	CbGpPWpGaD
Mianserin—HTR1F—Signaling Pathways—IL6—Parkinson's disease	3.18e-06	2.1e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling by GPCR—IL6—Parkinson's disease	3.17e-06	2.1e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—CYCS—Parkinson's disease	3.17e-06	2.09e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—ABCB1—Parkinson's disease	3.12e-06	2.06e-05	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—INS—Parkinson's disease	3.06e-06	2.02e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—INS—Parkinson's disease	3.05e-06	2.02e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—GSTM1—Parkinson's disease	3.03e-06	2e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—INS—Parkinson's disease	3e-06	1.98e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—INS—Parkinson's disease	3e-06	1.98e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—CASP3—Parkinson's disease	2.97e-06	1.96e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling by GPCR—IL6—Parkinson's disease	2.95e-06	1.95e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—MAPK8—Parkinson's disease	2.93e-06	1.94e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—GPX1—Parkinson's disease	2.9e-06	1.92e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	2.86e-06	1.89e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—COMT—Parkinson's disease	2.81e-06	1.85e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—CTGF—Parkinson's disease	2.8e-06	1.85e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—GSTP1—Parkinson's disease	2.79e-06	1.85e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—MAOA—Parkinson's disease	2.79e-06	1.84e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—HMOX1—Parkinson's disease	2.75e-06	1.82e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—INS—Parkinson's disease	2.73e-06	1.81e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—MAPK8—Parkinson's disease	2.73e-06	1.8e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—CASP3—Parkinson's disease	2.68e-06	1.77e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—MTHFR—Parkinson's disease	2.68e-06	1.77e-05	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—IL6—Parkinson's disease	2.68e-06	1.77e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling by GPCR—IL6—Parkinson's disease	2.66e-06	1.76e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—ABCB1—Parkinson's disease	2.64e-06	1.75e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	2.61e-06	1.73e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—CASP3—Parkinson's disease	2.59e-06	1.71e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—NQO1—Parkinson's disease	2.58e-06	1.71e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—CASP3—Parkinson's disease	2.57e-06	1.7e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling by GPCR—IL6—Parkinson's disease	2.57e-06	1.7e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—GSTM1—Parkinson's disease	2.57e-06	1.7e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling by GPCR—IL6—Parkinson's disease	2.56e-06	1.69e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—TH—Parkinson's disease	2.55e-06	1.68e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—CASP3—Parkinson's disease	2.5e-06	1.66e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—APOE—Parkinson's disease	2.49e-06	1.65e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling by GPCR—IL6—Parkinson's disease	2.49e-06	1.64e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—MAPK8—Parkinson's disease	2.46e-06	1.63e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—GPX1—Parkinson's disease	2.46e-06	1.62e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—CYCS—Parkinson's disease	2.44e-06	1.62e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—MAPK8—Parkinson's disease	2.38e-06	1.57e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—MAPK8—Parkinson's disease	2.37e-06	1.56e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—MAPK8—Parkinson's disease	2.3e-06	1.52e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—CASP3—Parkinson's disease	2.27e-06	1.5e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—MTHFR—Parkinson's disease	2.27e-06	1.5e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling by GPCR—IL6—Parkinson's disease	2.26e-06	1.49e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—CASP3—Parkinson's disease	2.24e-06	1.48e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—CASP3—Parkinson's disease	2.23e-06	1.47e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling by GPCR—IL6—Parkinson's disease	2.22e-06	1.47e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling by GPCR—IL6—Parkinson's disease	2.22e-06	1.46e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—COMT—Parkinson's disease	2.17e-06	1.43e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—GSTP1—Parkinson's disease	2.16e-06	1.42e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—MAOA—Parkinson's disease	2.15e-06	1.42e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—INS—Parkinson's disease	2.13e-06	1.41e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—HMOX1—Parkinson's disease	2.13e-06	1.4e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—APOE—Parkinson's disease	2.11e-06	1.4e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—MAPK8—Parkinson's disease	2.09e-06	1.38e-05	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—IL6—Parkinson's disease	2.08e-06	1.38e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—MAPK8—Parkinson's disease	2.05e-06	1.36e-05	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—IL6—Parkinson's disease	2.05e-06	1.36e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—MAPK8—Parkinson's disease	2.05e-06	1.36e-05	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—IL6—Parkinson's disease	2.05e-06	1.35e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—ABCB1—Parkinson's disease	2.04e-06	1.35e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—IL6—Parkinson's disease	2.04e-06	1.35e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—CASP3—Parkinson's disease	2.03e-06	1.34e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling by GPCR—IL6—Parkinson's disease	2.02e-06	1.34e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—GSTM1—Parkinson's disease	1.98e-06	1.31e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—GPX1—Parkinson's disease	1.9e-06	1.25e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—IL6—Parkinson's disease	1.87e-06	1.24e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—MAPK8—Parkinson's disease	1.87e-06	1.24e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—INS—Parkinson's disease	1.8e-06	1.19e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—MTHFR—Parkinson's disease	1.75e-06	1.16e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—IL6—Parkinson's disease	1.74e-06	1.15e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—APOE—Parkinson's disease	1.63e-06	1.08e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—IL6—Parkinson's disease	1.57e-06	1.04e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—IL6—Parkinson's disease	1.52e-06	1e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—IL6—Parkinson's disease	1.51e-06	9.99e-06	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—IL6—Parkinson's disease	1.47e-06	9.71e-06	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—INS—Parkinson's disease	1.39e-06	9.2e-06	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—IL6—Parkinson's disease	1.33e-06	8.81e-06	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—IL6—Parkinson's disease	1.31e-06	8.67e-06	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—IL6—Parkinson's disease	1.31e-06	8.65e-06	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—IL6—Parkinson's disease	1.19e-06	7.89e-06	CbGpPWpGaD
